Category Archives: Press Release

Easing of Regulatory Policies to Drive Global Demand for Companion Diagnostics, reports TMR

Due to the dominance of the top three players in the global companion diagnostics market, the nature of the market is highly oligopolistic, says Transparency Market Research in a new study. The leading companies operating in the market are focusing on protecting their patent rights to retain exclusivity. The top three companies in the companion diagnostics market are Roche Holdings followed by Qiagen N.V., and Agilent Technologies. Together they comprise approximately 80.4% of the overall global market in 2012.

Global Medical Tourism Market to Reach US$32.5 bn in 2019, Availability of Cost-effective Treatments in Emerging Nations Encourages Medical Tourism

A market study on the global tourism market, recently published by Transparency Market Research (TMR) estimates this market to rise at an exceptional CAGR of 17.90% over the period from 2013 to 2019 and reach a value US$32.5 bn by the end of the forecast period.The research report, titled “Medical Tourism Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” states that the worldwide medical tourism market attained a value of US$10.5 bn in 2012.

Browse the full Medical Tourism Market (India, Thailand, Singapore, Malaysia, Mexico, Brazil, Taiwan, Turkey, South Korea, Costa Rica, Poland, Dubai and Philippines) – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019 report at

Global Atrial Fibrillation Market to Touch US$14.8 bn by 2019; Graying Population and Chronic Disease Prevalence Drive Growth

Atrial fibrillation, a condition whose symptoms are irregular and/or rapid heartbeats, affected an estimated 33.5 mn individuals worldwide as of 2010. The World Health Organization (WHO) has termed the condition as a “growing global health concern”. In order to further understand how the market for global atrial fibrillation market treatments is developing, Transparency Market Research has published a report, titled ‘Atrial Fibrillation Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.’ According to the estimations of TMR’s study, the market is expected to rise at a compounded annual growth rate (CAGR) of 13.4% between 2013 and 2019. The report further states that the market stood at a valuation of US$6.1 bn in 2012 and will touch US$14.8 bn by 2019.

Nonalcoholic Steatohepatitis (NASH) Therapeutics Market to Reach US$20.27 bn by 2025, Elafibranor Projected to Spur Growth

According to a new market report published by Transparency Market Research “Nonalcoholic Steatohepatitis Therapeutics Market – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2025”, the nonalcoholic steatohepatitis (NASH) therapeutics market is anticipated to expand at a CAGR of 10.7% from 2015 to 2025 to reach US$20.27 bn by 2025.

Browse the full Nonalcoholic Steatohepatitis Therapeutics Market (Obeticholic Acid, Aramchol, Saroglitazar, and Elafibranor) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 – 2025 report at

Opioid Induced Constipation Treatment Providers to Look to Large Untapped Regions for Improved Sales, reports TMR

Takeda Pharmaceuticals Company, Ltd., with its approved drug Amitiza, holds a majority share in the global market for opioid induced constipation treatment. In 2014 the top three players – Takeda, Valeant Pharmaceuticals International, Ltd., and Boehringer Ingelheim – operated on a collective share of 91.8% of the global market.

This is a highly consolidated market but with a large scope for the prominent players to penetrate regions other than North America.

Transparency Market Research’s recent publication reveals the possibilities that players in the global market for opioid induced constipation treatment can take up to improve their global standing in the market. This includes reaching out to the emerging economies and gain shares from a currently untapped market.

Pre-owned Medical Devices Market: Demand for Pre-owned X-Ray and Mammography Machines Propels Global Market at 10.60% CAGR 2013-2019

A new Transparency Market Research report states that the global pre-owned medical devices market stood at US$2.4 mn in 2012 and is predicted to reach US$4.9 mn by 2019. It is predicted to expand at a CAGR of 10.60% from 2013 to 2019. The title of the report is “Pre-Owned Medical Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019.” The current condition of the market and the future growth prospects of the market have been elaborated upon in detail in this report.

Global Neurology Devices Market to Reach US$13.6 bn by 2019 due to High Incidence of Neurological Diseases

Transparency Market Research has published a comprehensive research report that explains the global neurology devices market in absolute detail. The research report, titled “Neurology Devices Market – Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013 – 2019,” closely observes the key trends and dynamics in the global neurology devices market. The report also offers an explanation of the strengths, the weaknesses, the opportunities, and the threats in the market with the help of SWOT analysis. Furthermore, it also evaluates the threat of new entrants, the threat of substitute products or services, the bargaining power of customers, the bargaining power of suppliers, and the intensity of competitive rivalry.According to the research report, the global neurology devices market is expected to be worth US$13.6 bn by the end of 2019, up from US$5.0 bn in 2012, expanding at a CAGR of 15.4% from 2013 to 2019.

Looming Patent Expiry of Blockbuster Drugs to Negatively Influence Demand for Hospital Pharmaceuticals Globally, Forecasts TMR

The looming patent expiry of blockbuster drugs and the need for maintaining the flow of novel therapeutics have led to realization that pharmaceutical companies cannot allow the status quo to remain as it is. Collaborating with other key players has thus become a popular strategy among leading enterprises vying to benefit from a stronger product pipeline.

As per Transparency Market Research, Sanofi, Roche, Novartis, and Pfizer dominated the global hospital pharmaceuticals market in 2014, collectively holding a share of 18.6%. Among these companies, Novartis held the dominant share of 5.5% in the global market, followed by Pfizer that held 4.8% share in the global market.

Stringent Regulations Implemented to Ensure Highest Standards of Packaging and Labeling Services in Healthcare Industry

With eight key companies accounting for a mere share of 20.3% in 2014, the global packaging and labeling market exhibits a highly competitive vendor landscape. Among leading enterprises in the market, WestRock Company held 5.5% of the global market in 2014, which was the largest share held by any company. The company has managed to seal its dominance in the market with a strong and diverse product portfolio in the sector of healthcare packaging and a considerable geographic presence. Amcor Limited emerged as the second leading company in the global packaging and labeling market the same year, finds TMR.

Designed by
Powered by